2021 MedCan Speaker

Dr Rachel Galettis

Clinical Trial Manager,
Australian Centre for Cannabinoid Clinical and Research Excellence (ACRE)

Is the Clinical Trial Manager at the Centre of Drug Repurposing and Medicines Research at the University of Newcastle.

She is responsible for managing new and ongoing clinical trials for the Australian Centre for Cannabinoid Clinical and Research Excellence (ACRE), a National Health and Medical Research Council Centre of Research Excellence, to support quality evidence for the use of cannabis medicines.
This includes the NSW-wide study, Cannabinoids for Symptom Control in Advanced Cancer, An Open Label Prospective Clinical Trial in NSW (CARE NSW), funded by NSW Health through the NSW Clinical Cannabis Medicines Program.

ACRE provides Rachel with the opportunity to combine her research passions of natural product pharmacology; consumer reported outcomes and the design and execution of quality clinical trials.

Her early career included a PhD in New Zealand on the dietary chemoprevention of Pacific Island foods, before she moved to Australia and undertook pre-clinical and clinical research with isolated natural compounds. This, together with her subsequent coordination of the Australian Corneal Graft Registry and a large international multisite cancer trial for TROG Cancer Research, provided her with the necessary skills, understanding and appreciation of the complexities a clinical trial of cannabis medicines involve.


All Sessions by Dr Rachel Galettis

Day 1 - Industry Summit - 10 February

Time Science Stream
15:00
Science
Dr Rachel Galettis 
Clinical Trial Manager, Australian Centre for Cannabinoid Clinical and Research Excellence (ACRE)

More Speakers

Graham Gulbransen

Cannabis Consultant, Addiction Specialist, General Practitioner

Kristen Lunman

Co-Founder and GM

Andrew Cameron

Principal Consultant

Eva Neshat

Founder and Chief Executive Officer